ArticleClinical immunology (Orlando, Fla.)2024
High symptom burden in female X-linked chronic granulomatous disease carriers.
Abstract read
In one paragraph
Article in Clinical immunology (Orlando, Fla.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- How I Treat: Chronic granulomatous disease.Journal of human immunity · 2026Review
- Skewed X-Chromosome Inactivation in a Child with Fungal Pneumonia and a Pathogenic de novo CYBB Variant.Indian journal of pediatrics · 2026Article
- Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers.Clinical immunology (Orlando, Fla.) · 2026Article
- Perspectives on chronic granulomatous disease: results of a clinician survey.Frontiers in immunology · 2026Article
- The type 1 and type 3 immune responses underlying the tissue inflammation associated with NOX2 deficiency.Frontiers in immunology · 2026Review
- Phagocyte NADPH Oxidase NOX2-Derived Reactive Oxygen Species in Antimicrobial Defense: Mechanisms, Regulation, and Therapeutic Potential-A Narrative Review.Antioxidants (Basel, Switzerland) · 2025Review
- The Role of NADPH Oxidase 2 in Leukocytes.Antioxidants (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Mary Ann MirandaDivision of Allergy and Immunology, Department of Pediatrics, University of South Florida, Tampa, FL, United States of America.
Athanasios TsalatsanisResearch Methodology and Biostatistics, Morsani College of Medicine, University of South Florida, Tampa, FL, United States of America.
Jessica R TrotterDivision of Allergy and Immunology, Department of Pediatrics, University of South Florida, Tampa, FL, United States of America.
Danielle E ArnoldNational Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Jacqueline D SquireDivision of Pulmonology, Allergy, and Sleep Medicine, Mayo Clinic, Jacksonville, FL, United States of America.
Sharon KiddPediatric Allergy, Immunology, and Blood and Marrow Transplant Division, Department of Pediatrics, University of California, San Francisco and UCSF Benioff Children's Hospital, San Francisco, CA, United States of America.
Suhag ParikhDepartment of Pediatrics, Emory University and Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States of America.
Rebecca A MarshDivision of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, United States of America.
Linda M GriffithDivision of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Kanwaldeep MallhiFred Hutchinson Cancer Research Center, University of Washington, Department of Pediatrics and Seattle Children's Hospital, Seattle, WA, United States of America.
Deepak ChellapandianCenter for Cell and Gene Therapy for Non-Malignant Conditions, Johns Hopkins All Children's Hospital, St Petersburg, FL, United States of America.
Stephanie Si LimUniversity of Hawaii Cancer Center, Honolulu, HI, United States of America.
Eyal GrunebaumDivision of Immunology and Allergy, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Kathleen E SullivanDivision of Allergy and Immunology, Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, United States of America.
Peter E NewburgerDepartment of Pediatrics, UMass Chan Medica School, Worcester, MA, United States of America.
Mary C DinauerDepartment of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, MO, United States of America.
Morton J CowanPediatric Allergy, Immunology, and Blood and Marrow Transplant Division, Department of Pediatrics, University of California, San Francisco and UCSF Benioff Children's Hospital, San Francisco, CA, United States of America.
Christopher C DvorakPediatric Allergy, Immunology, and Blood and Marrow Transplant Division, Department of Pediatrics, University of California, San Francisco and UCSF Benioff Children's Hospital, San Francisco, CA, United States of America.
Elie HaddadDepartment of Pediatrics, Centre Hospitalier Universitaire (CHU) Sainte-Justine, University of Montreal, Montreal, QC, Canada.
Donald B KohnDepartment of Pediatrics, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, United States of America.
Luigi D NotarangeloLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Sung-Yun PaiNational Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Jennifer M PuckPediatric Allergy, Immunology, and Blood and Marrow Transplant Division, Department of Pediatrics, University of California, San Francisco and UCSF Benioff Children's Hospital, San Francisco, CA, United States of America.
Michael A PulsipherDivision of Pediatric Hematology and Oncology, Intermountain Primary Children's Hospital, Huntsman Cancer Institute at the University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT, United States of America.
Troy R TorgersonAllen Institute for Immunology, Seattle, WA, United States of America.
Harry L MalechLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Elizabeth M KangLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Felicia B MortonCGD Association of America, New York City, NY, United States of America.
Jennifer W LeidingDivision of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD, United States of America; Institute for Clinical and Translational Research, St. Petersburg, FL, United States of America; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, FL, United States of America.
Funding
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2MPB vs. BMU01HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2001 to 2010
$63.3MRare Diseases Data Management and Coordinating CenterU01TR001263 · NCATS · UNIVERSITY OF SOUTH FLORIDA · PI KRISCHER, JEFFREY P · 2014 to 2018
$28.1MTraining of Clinical Investigators in Primary Immune DeficienciesU54AI082973 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PUCK, JENNIFER M. · 2009 to 2023
$23.3MData Management and Coordinating Center (DMCC)U54NS064808 · NINDS · UNIVERSITY OF SOUTH FLORIDA · PI KRISCHER, JEFFREY P · 2009 to 2013
$16.5MCharacterization of the cellular and molecular bases of inborn errors of immunityZIAAI001222 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NOTARANGELO, LUIGI · 2017 to 2025
$15.2MPrimary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunityR24AI184316 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Christopher Craig Dvorak, Elie Haddad · 2024 to 2026
$5.3MBlood and Marrow Transplant Clinical Trials NetworkU10HL069254 · NHLBI · UNIVERSITY OF UTAH · PI PULSIPHER, MICHAEL A · 2011 to 2016
$839kIntramural NIH HHS ZIA AI001222NCATS NIH HHS U01 TR001263NCI NIH HHS U24 CA076518NHLBI NIH HHS U01 HL069294NHLBI NIH HHS U10 HL069254NIAID NIH HHS R24 AI184316NIAID NIH HHS U54 AI082973NINDS NIH HHS U54 NS064808
Abstract
PubMed holds no abstract for this paper.
Indexed as
CGDHeterozygoteXL-CGD
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.